# Pharmacist-Led Flu Vaccination Services in Romanian Community Pharmacies: Barriers, Perceptions, and Implementation Challenges

**Authors:** Marius Calin Chereches, Mihaela Simona Naidin, Alexandra Grosan, Radu Antoniu Patrascu, Anca-Maria Capraru, Marina Daniela Dimulescu, Adina Turcu-Stiolica

PMC · DOI: 10.3390/pharmacy14010036 · Pharmacy · 2026-02-12

## TL;DR

This study explores why most Romanian pharmacies do not offer flu vaccinations, highlighting financial and staff-related barriers and suggesting tailored policy solutions.

## Contribution

The study identifies barriers and readiness among non-vaccinating pharmacies in Romania, addressing a critical knowledge gap.

## Key findings

- Independent pharmacies want to offer vaccinations but face high costs.
- National chains have resources but face staff resistance to vaccination services.
- Pharmacist professional identity issues hinder the adoption of clinical roles.

## Abstract

Although pharmacist-led vaccination is a global standard for expanding immunization coverage, its adoption in Romania remains at an early stage. While previous studies have focused on early adopters, this research evaluates barriers, perceptions, and readiness among community pharmacies that do not yet provide this service, thereby addressing a critical knowledge gap regarding the “non-vaccinating” majority. A cross-sectional mixed-methods study was conducted among 208 pharmacists representing national chains, regional networks, and independent pharmacies. Quantitative data were analyzed using Chi-square tests and Spearman correlations to identify structural disparities, while a thematic analysis was employed to explore qualitative insights related to professional identity and operational barriers. We identified a clear mismatch between pharmacies’ willingness to provide vaccination services and their practical ability to implement them. Independent pharmacies demonstrated a strong intention to adopt vaccination services (71.4%) but were limited by financial constraints, with high implementation costs identified as a significant barrier (p = 0.014). In contrast, national pharmacy chains had sufficient resources yet faced marked staff resistance, with 43.9% reporting extreme reluctance (p = 0.038). These chains were concentrated in the capital region (p = 0.002), thereby positioning other pharmacies as key providers in underserved areas. Furthermore, thematic analysis revealed a deep-seated “professional identity” crisis, in which pharmacists struggle with the transition from medication specialists to clinical practitioners. The expansion of vaccination services cannot rely on a “one-size-fits-all” strategy. Successful national implementation requires a segmented policy approach, including financial subsidies to support independent pharmacies, change management strategies to engage the corporate workforce, and targeted regulatory education for regional networks to prevent vaccination deserts.

## Full-text entities

- **Diseases:** anaphylaxis (MESH:D000707), herpes zoster (MESH:D006562), COVID-19 (MESH:D000086382), flu (MESH:D007251), injury to (MESH:D014947)
- **Species:** Homo sapiens (human, species) [taxon 9606], Respiratory syncytial virus (no rank) [taxon 12814]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12921818/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12921818/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12921818/full.md

---
Source: https://tomesphere.com/paper/PMC12921818